{
    "Trade/Device Name(s)": [
        "BD Veritor\u2122 System Flu A+B Assay",
        "BD Veritor System for Rapid Detection of Flu A+B",
        "BD Veritor System Flu A+B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K132692",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112277",
        "K132239"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "August 23, 2013",
    "Summary Letter Received Date": "August 29, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Colloidal gold detection"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Reader",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System Flu A+B rapid chromatographic immunoassay to qualitatively detect influenza A and B antigens in nasal and nasopharyngeal swabs",
    "Indications for Use Summary": "Aids in the diagnosis of influenza A and B viral infections by direct and qualitative detection of nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients",
    "fda_folder": "Microbiology"
}